Heqet Therapeutics
PrivateLast Round
Series A
Mar 23, 2022
Total Funding Raised
$8.7M
Company Overview
Heqet Therapeutics is a biotechnology company that develops non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heqet Therapeutics Comparables
Compare Heqet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolifagen | 85% | |
| Jaan Biotherapeutics | 84% | |
| Summa Biotech BV | 84% | |
Heqet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2022 |
Heqet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsche Balaton | Series A |
| Claris Ventures | Series A |
| 2invest AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 122% MoM, reaching 1.1K.
- Nov 18, 2024
Monthly visitors increased 45% MoM.
Heqet Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Heqet Therapeutics's valuation, stock price, and market status.